SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-018553
Filing Date
2021-05-06
Accepted
2021-05-06 21:34:31
Documents
1
Period of Report
2021-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 33862
  Complete submission text file 0000899243-21-018553.txt   40625
Mailing Address C/O THE BLACKSTONE GROUP 345 PARK AVE NEW YORK NY 10154
Business Address
SCHWARZMAN STEPHEN A (Reporting) CIK: 0001070844 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21899991

Mailing Address 345 PARK AVENUE NEW YORK NY 10154
Business Address 345 PARK AVENUE NEW YORK NY 10154 (212) 583-5000
Blackstone Group Inc (Reporting) CIK: 0001393818 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21899993
SIC: 6282 Investment Advice
Office of Finance

Mailing Address 345 PARK AVENUE NEW YORK NY 10154
Business Address 345 PARK AVENUE NEW YORK NY 10154 (212) 583-5000
Blackstone Group Management L.L.C. (Reporting) CIK: 0001404071 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21899992

Mailing Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154 2125835000
Blackstone Holdings I L.P. (Reporting) CIK: 0001464694 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21899996

Mailing Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154 2125835000
Blackstone Holdings I/II GP L.L.C. (Reporting) CIK: 0001464695 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21899994

Mailing Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154 212-583-5000
Blackstone Holdings II L.P. (Reporting) CIK: 0001484870 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21899995

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences III, L.P. (Reporting) CIK: 0001597143 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1214
Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21900000

Mailing Address C/O CLARUS VENTURES 101 MAIN STREET, SUITE 1210 CAMBRIDGE MA 02142
Business Address C/O CLARUS VENTURES 101 MAIN STREET, SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Ventures III GP, L.P. (Reporting) CIK: 0001620148 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21899999

Mailing Address C/O THE BLACKSTONE GROUP L.P. 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O THE BLACKSTONE GROUP L.P. 345 PARK AVENUE NEW YORK NY 10154 212-583-5000
Blackstone Clarus III L.L.C. (Reporting) CIK: 0001762202 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21899998

Mailing Address C/O THE BLACKSTONE GROUP INC. 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O THE BLACKSTONE GROUP INC. 345 PARK AVENUE NEW YORK NY 10154 212-583-5000
Blackstone Clarus GP L.P. (Reporting) CIK: 0001793311 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21899997

Mailing Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202
Business Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202 502-569-1059
Talaris Therapeutics, Inc. (Issuer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences